心臟幫浦設備市場規模、佔有率及成長分析（按產品、類型、療法和地區）- 產業預測 2025-2032

2023 年心臟幫浦設備市場規模價值為 31 億美元，預計將從 2024 年的 37.8 億美元成長到 2032 年的 185.6 億美元，預測期內（2025-2032 年）的複合年成長率為 22.0%。

由於心血管疾病發病率不斷上升以及心臟衰竭發病率不斷上升，全球心臟泵設備市場正在經歷強勁成長。我們全面的價值鏈分析可協助製造商透過創新獲得競爭優勢。人口老化進一步推動了對這些關鍵設備的需求，這些設備對於支持患有嚴重心臟疾病的患者至關重要。小型化和增強功能等技術進步顯著提高了患者的治療效果和採用率。特別是磁浮輔助人工心臟（VAD）的出現改變了整個醫療體系，它能夠提供卓越的心臟支持並且併發症更少。此外，對於合格移植的病人，轉向機械循環支援作為永久的解決方案正在擴大市場機會，特別是在美國，預計該市場將以持續的複合年成長率成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究分析

心臟泵設備市場規模（按產品和複合年成長率） (2025-2032)

• 市場概況
• 輔助人工心臟
  • 左心室輔助裝置
  • 經皮心室輔助裝置
  • 雙心室輔助裝置
  • 右心室輔助裝置
• 主動脈內球囊泵
• 人工心臟總數

心臟泵設備市場規模（按類型和複合年成長率）（2025-2032）

• 市場概況
• 植入式心臟幫浦裝置
• 體外心臟幫浦裝置

心臟幫浦設備市場規模（依療法和複合年成長率） (2025-2032)

• 市場概況
• 植入式輔助人工心臟(BTT)
• 移植登記橋樑（BTC）
• 目的地治療（DT）
• 其他治療方法

心臟泵設備市場規模（按地區分類）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Abbott Laboratories（US）
• Medtronic PLC（Ireland）
• LivaNova PLC（United Kingdom）
• Berlin Heart GmbH（Germany）
• Getinge AB（Sweden）
• Terumo Corporation（Japan）
• Teleflex Incorporated（US）
• Jarvik Heart, Inc.（US）
• Fresenius Medical Care AG & Co. KGaA（Germany）
• Calon Cardio（United Kingdom）
• BiVACOR Inc.（Australia）
• Leviticus Cardio Ltd.（Israel）
• CARMAT SA（France）
• FineHeart SA（France）
• MyLVAD（US）
• MicroPort Scientific Corporation（China）
• TandemLife, a LivaNova company（US）

結論和建議

Heart Pump Device Market size was valued at USD 3.1 billion in 2023 and is poised to grow from USD 3.78 billion in 2024 to USD 18.56 billion by 2032, growing at a CAGR of 22.0% during the forecast period (2025-2032).

The global heart pump device market is witnessing robust growth, driven by the rising prevalence of cardiovascular diseases and the increasing incidence of heart failure. As manufacturers leverage our comprehensive value chain analysis, they can enhance their competitive advantage through innovation. The aging population is further fueling demand for these critical devices, essential for supporting patients with severe cardiac conditions. Technological advancements, such as miniaturization and improved functionality, have significantly boosted patient outcomes and adoption rates. Notably, the emergence of magnetically levitated ventricular assist devices (VADs) has transformed the landscape, offering superior heart support with fewer complications. Additionally, the shift towards mechanical circulatory support as a permanent solution for patients ineligible for transplant is expanding market opportunities, particularly in the U.S., where sustainable CAGR growth is anticipated.

Top-down and bottom-up approaches were used to estimate and validate the size of the Heart Pump Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Heart Pump Device Market Segments Analysis

Global Heart Pump Device Market is segmented by Product, Type, Therapy and region. Based on Product, the market is segmented into Ventricular Assist Devices, Intra-Aortic Balloon Pumps and Total Artificial Hearts. Based on Type, the market is segmented into Implantable Heart Pump Devices and Extracorporeal Heart Pump Devices. Based on Therapy, the market is segmented into Bridge-To-Transplant (BTT), Bridge-To-Candidacy (BTC), Destination Therapy (DT) and Other Therapies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Heart Pump Device Market

Continuous innovation in heart pump technology has tremendously enhanced the performance and efficacy of these devices, driving the Heart Pump Device market. Recent advancements have produced smaller, more resilient, and efficient heart pumps, significantly boosting patient comfort and overall quality of life. A notable example is the emergence of magnetically levitated ventricular assist devices (LVADs), which have minimized device-related complications while yielding better patient outcomes. This ongoing development not only addresses the immediate needs of patients with heart failure but also underscores the commitment of manufacturers to improve heart pump solutions, ultimately expanding market potential and fostering growth in the healthcare industry.

Restraints in the Heart Pump Device Market

The heart pump device market faces notable constraints primarily due to the intricate and advanced nature of these medical technologies, which results in high manufacturing and acquisition costs. This substantial financial burden impacts patients, healthcare providers, and healthcare systems, limiting access to these essential devices. Additionally, inadequate reimbursement coverage for heart pump devices in certain areas further complicates the situation, making it challenging for patients to obtain these critical technologies. As a result, the combination of prohibitive costs and limited financial support inhibits the widespread adoption and utilization of heart pump devices, ultimately affecting patient care and outcomes.

Market Trends of the Heart Pump Device Market

The Heart Pump Device market is witnessing a notable trend towards the integration of compatible devices that enhance pump performance and patient outcomes. This includes advanced control units that optimize pump flow management and tailored power sources providing extended battery life, ensuring uninterrupted operation. Furthermore, the incorporation of sophisticated monitoring and data management features facilitates real-time remote patient tracking, significantly improving care coordination. As healthcare providers increasingly prioritize personalized, efficient solutions, the surge in demand for these compatible technologies is transforming the landscape of cardiovascular care, driving innovation and growth within the heart pump device sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global Heart Pump Device Market Size by Product & CAGR (2025-2032)

• Market Overview
• Ventricular Assist Devices
  • Left Ventricular Assist Devices
  • Percutaneous Ventricular Assist Devices
  • Biventricular Assist Devices
  • Right Ventricular Assist Devices
• Intra-Aortic Balloon Pumps
• Total Artificial Hearts

Global Heart Pump Device Market Size by Type & CAGR (2025-2032)

• Market Overview
• Implantable Heart Pump Devices
• Extracorporeal Heart Pump Devices

Global Heart Pump Device Market Size by Therapy & CAGR (2025-2032)

• Market Overview
• Bridge-To-Transplant (BTT)
• Bridge-To-Candidacy (BTC)
• Destination Therapy (DT)
• Other Therapies

Global Heart Pump Device Market Size & CAGR (2025-2032)

• North America (Product, Type, Therapy)
  • US
  • Canada
• Europe (Product, Type, Therapy)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Type, Therapy)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Type, Therapy)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Type, Therapy)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Berlin Heart GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jarvik Heart, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care AG & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Calon Cardio (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BiVACOR Inc. (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leviticus Cardio Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CARMAT SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FineHeart SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MyLVAD (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TandemLife, a LivaNova company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations